NAII · CIK 0000787253 · FY2025 live · 2025-06-30
NATURAL ALTERNATIVES INTERNATIONAL INC
View as
Model
Classic Z
FY2025
1.09
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
46.36
0–100 · Classic Z tape · not a PD
Book standing
48
Year change
—
Market PD
—
O-score
42
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
1.09
Z″ 3.07
Score 1.09 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.201.2 × = 0.24X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
0.391.4 × = 0.55X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.063.3 × = −0.19X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.820.6 × = 0.49X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
NATURAL ALTERNATIVES INTERNATIONAL INC is on classic Z at 1.09 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print; book equity / liabilities is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 68th percentile in Healthcare.
- TARSDistressTarsus Pharmaceuticals, Inc.1.09
- CARLDistressCARLSMED, INC.1.07
- ANRODistressAlto Neuroscience, Inc.1.07
- OFIXDistressOrthofix Medical Inc.1.07
- COLLDistressCOLLEGIUM PHARMACEUTICAL, INC1.06
- SMMTDistressSummit Therapeutics Inc.1.04
- RDYDistressDR REDDYS LABORATORIES LTD1.15
- TRDADistressEntrada Therapeutics, Inc.1.15
KPI widgets
Current assets
$59M
Total assets
$152M
Current liabilities
$29M
Total liabilities
$84M
Working capital
$30M
Retained earnings
$59M
EBIT
−$9M
Total sales
$0
Book equity
$68M
Accession 0001437749-25-029731. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-06-30). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.